- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02259153
Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis
October 3, 2014 updated by: Fernando Civeira, Instituto Aragones de Ciencias de la Salud
A Randomized Study to Assess the Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis
The objective of the study is to assess the effect of two diets with different fat composition on cholesterol metabolism.
The study was a randomized cross-over trial where volunteers follow two study periods with different types of meat (lean and fat red meat) separately by a ten days wash-out period.
At the beginning of the study and after the study periods the following parameters are determined: anthropometric (weight, waist, circumference and body mass index), blood pressure, dietary (72-hours dietary registry) and exercise assessments and biochemical analysis (total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, apolipoprotein A1, apolipoprotein B, iron, transferring, ferritin, uric acid, glucose, HbA1c and insulin).
Serum concentration of non cholesterol sterols (sitosterol, campesterol, stigmasterol, desmosterol and lanosterol) and oxysterols (24S-hydroxycholesterol, 27-hydroxycholesterol and 7α-hydroxycholestenone) were measured by High Performance Liquid Chromatography tandem Mass Spectrometry in these subjects throughout along the study in order to demonstrate the effect of different red meat on the hepatic metabolism of cholesterol.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Normolipemic healthy subjects defined by levels of LDL cholesterol and triglycerides below the 90th percentile adjusted for age and sex.
- Diet and stable lifestyle with controllable feeding.
Exclusion Criteria:
- Pregnancy or intention of pregnancy during the study.
- Lipid lowering drugs in the last 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Lean red meat diet
Participants were given 350 g per day of lean red meat to incorporate to their usual diet for ten days.
|
|
ACTIVE_COMPARATOR: Fat red meat diet
Participants were given 350 g per day of fat red meat to incorporate to their usual diet for ten days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in lipid profile
Time Frame: Baseline and after 10 days of intervention
|
Baseline and after 10 days of intervention
|
Changes in non cholesterol sterols and oxysterols serum concentrations
Time Frame: Baseline and after 10 days of intervention
|
Baseline and after 10 days of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lucía Baila-Rueda, MSc, Unidad de Lípidos/ Laboratorio de Investigación Molecular; Hospital Universitario Miguel Servet; Instituto Aragonés de Ciencias de la Salud (Zaragoza, Spain)
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (ACTUAL)
May 1, 2014
Study Completion (ACTUAL)
August 1, 2014
Study Registration Dates
First Submitted
October 1, 2014
First Submitted That Met QC Criteria
October 3, 2014
First Posted (ESTIMATE)
October 8, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
October 8, 2014
Last Update Submitted That Met QC Criteria
October 3, 2014
Last Verified
October 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEICA;PI13-00106
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lipid Metabolism Disorders
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingLipid Metabolism DisorderUnited States
-
Université de SherbrookeHospices Civils de LyonCompleted
-
Merck Sharp & Dohme LLCCompletedLipid Metabolism Disorder
-
Organon and CoCompleted
-
Luye Pharma Group Ltd.CompletedLipid Metabolism DisorderUnited States
-
Hasselt UniversityRecruitingExercise | Sedentary Behavior | Lipid Metabolism DisorderBelgium
-
Johns Hopkins UniversityVAP Diagnostics LabActive, not recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
NewAmsterdam PharmaUniversity of PennsylvaniaRecruiting
-
Shandong Provincial HospitalRecruitingMetabolism and Nutrition Disorder | Rhythm Nodal | Metabolism Disorder, LipidChina
Clinical Trials on Changes in cholesterol metabolism
-
Benha UniversityRecruitingCOVID-19 | Tachycardia | Cardiac Arrhythmia | Stress Reaction | Accommodation SpasmEgypt
-
Medical University of ViennaCompletedPrimary Open Angle Glaucoma | Glaucoma | Pseudoexfoliation GlaucomaAustria
-
Respironics, California, Inc.Terminated
-
xiangming fangRed Cross Hospital, Hangzhou, China; The Central Hospital of Lishui CityNot yet recruitingAnesthesia | Thoracic Surgery | Tracheal Intubation
-
University of LuebeckRecruiting
-
HealthPartners InstituteCompleted
-
Centre Hospitalier Universitaire DijonCompletedCOVID-19 Severe Pneumonia | Severe Pneumonia Due to Other PathogeneFrance
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedGynecologic Cancer | Surgery | Anesthesia | Hysterectomy | Gynecologic DiseaseItaly
-
Eliz ArterCyprus Science UniversityCompleted
-
Boston Children's HospitalCompleted